ArticleHuman vaccines & immunotherapeutics2026
Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
China approved human papillomavirus (HPV) vaccines for women and men in 2016 and 2025 respectively. We aimed to online survey the knowledge of HPV and HPV vaccines, as well as the vaccine uptake, among medical college students in Inner Mongolia, during April 1-21, 2026. Of 5,846 eligible students, 660 (11.3%) participated in the survey. Fourteen respondents were excluded because of their incomplete questionnaires. Of 646 respondents aged 20.5 (±1.5) years with 65.5% (423) females, 93.6% and 87.6% were aware of HPV and HPV vaccines respectively. However, only 74.8% of them knew HPV as the main cause of cervical cancer and 73.5% knew the preventive effect of HPV vaccines against cervical cancer. Fewer respondents knew the association of HPV with other cancers. The males had less knowledge than females. Only 115 (27.2%) females had received HPV vaccination, and none of the males did due to transient availability of the vaccine for males. Family income, paternal education, and HPV vaccine knowledge were the main factors associated with the vaccination. The vaccination barriers included vaccine cost, perceived lack of necessity, doubts about effectiveness, concerns about adverse events, and unawareness of where to get vaccinated. Among the unvaccinated respondents, 61.4% (137/223) of the males and 86.4% (266/308) of the females intended to get vaccinated. The survey revealed gaps in HPV and HPV vaccine knowledge, as well as low vaccination coverage among medical students. The results indicate that enhancing education about HPV and HPV vaccines appears valuable for increasing HPV vaccine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.